Publications by authors named "D E Zembower"

Claim this Profile
M
Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents.
David E Zembower, Yongping Xie, Ali Koohang, Mary J Kuffel, Matthew M Ames

Anticancer Agents Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Vincent Sandanayaka, Bjorn Mamat, Rama K Mishra, Jennifer Winger, Michael Krohn, David E Zembower

J Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent that does not prolong bleeding.
Jasbir Singh, Wayne Zeller, Nian Zhou, Georgeta Hategan, Rama K Mishra, David E Zembower

J Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051.
Livia A Enache, Jun Zhang, David W Sullins, Isaac Kennedy, Emmanuel Onua, David E Zembower

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
Douglas R Davies, Bjorn Mamat, Olafur T Magnusson, Jeff Christensen, Magnus H Haraldsson, David Zembower

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis